A2 Biotherapeutics, Inc.
Biotechnology-Research
Website
Company Tagline
Powerful & precise T cell therapy that attacks solid tumors while sparing normal cells.
Industry Category
Business Keywords
Company Description
A2 Biotherapeutics, Inc. is a pioneering biotechnology research company dedicated to transforming medicine and turning the tide on cancer. Focused on the next frontier in cell therapy, A2 Biotherapeutics engineers T cells that precisely target the loss of genetic material in solid tumors. This innovative approach enables the selective killing of tumor cells, leaving normal cells unharmed.
Located at 30301 Agoura Road, Suite 210, Agoura Hills, CA 91301, US, A2 Biotherapeutics is committed to pushing the boundaries of science. With a strong foundation in biotechnology, research, and drug development, A2 Biotherapeutics specializes in oncology, manufacturing, target identification, cell therapy, and immunotherapy. The company's powerful and precise T cell therapy aims to revolutionize the treatment of solid tumors.
A2 Biotherapeutics is poised for continued growth and commercial development. We invite the manager of A2 Biotherapeutics to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.
A2 Biotherapeutics, Inc. est une entreprise pionnière de recherche biotechnologique dédiée à la transformation de la médecine et à la lutte contre le cancer. Axée sur la prochaine frontière de la thérapie cellulaire, A2 Biotherapeutics conçoit des cellules T qui ciblent précisément la perte de matériel génétique dans les tumeurs solides. Cette approche innovante permet la destruction sélective des cellules tumorales, laissant les cellules normales intactes.
Située au 30301 Agoura Road, Suite 210, Agoura Hills, CA 91301, États-Unis, A2 Biotherapeutics s'engage à repousser les limites de la science. Forte d'une solide base en biotechnologie, en recherche et en développement de médicaments, A2 Biotherapeutics se spécialise dans l'oncologie, la fabrication, l'identification de cibles, la thérapie cellulaire et l'immunothérapie. La thérapie cellulaire puissante et précise de l'entreprise vise à révolutionner le traitement des tumeurs solides.
A2 Biotherapeutics est prête pour une croissance continue et un développement commercial. Nous invitons le responsable de A2 Biotherapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer davantage leur présence sur le marché.
Key Personnel / Employees
Compare Companies Side by Side
Compare A2 Biotherapeutics, Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
A2 Biotherapeutics, Inc.Main Company |
Im
ImmPACT BioView Profile |
Poseida Therapeutics...View Profile |
NKGen Biotech, Inc.View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2017 | 2014 | 2017 |
|
Company Size
|
— | 51-200 | 201-500 | 51-200 |
|
City
|
Agoura Hills, CA | West Hills, California | San Diego, California | Santa Ana, California |
|
Country
|
United States | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Cell Therapy
Oncology
Immunotherapy
Drug Development
T cell therapy
Tumor treatment
Research
Manufacturing
Target Identification
|
7 Total
7 Unique
Unique Skills:
autoimmune
Cancer Therapy
CAR-T
Logic gate
lupus
On target off tumor toxicity
+1
|
20 Total
20 Unique
Unique Skills:
Adoptive Cell Therapy
Allogeneic
CAR-T cells
Cas-CLOVER™
Cytotoxic T Lymphocytes
Gene Editing
+14
|
9 Total
9 Unique
Unique Skills:
Allogeneic Cell Therapy
Alzheimer's Disease
Autologous Cell Therapy
Biopharmaceutical
Cellular Therapeutics
Immuno-oncology
+3
|
4
Total Companies2014
Oldest Founded1
Countries45
Unique SkillsSimilar Companies
Other organizations in the same industry
T&RBiofab
Biotechnology-ResearchWhere bioprinting, stem cells and biomaterials meet to change people's lives
KaliVir Immunotherapeutics
Biotechnology-ResearchKaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer trea...
Lumos Diagnostics
Biotechnology-ResearchLumos (ASX:LDX) develops, manufactures and commercializes custom, rapid point-of-care diagnostic tec...
inbiome
Biotechnology-ResearchRadically accelerating human healthcare
Alternative Company Names
This company is also known as